MAP2K7 and lung carcinoma: Consistent with our results, other groups have shown that inhibition of the PI3K/Akt/mTORC1 pathway leads to activation of the Ras/MEK/ERK signaling cascade in lung cancer cells, and this is dictated by the K-Ras and c-Met status and the protein phosphatase activity [28].